Private health insurers will be required to cover the costs for up to eight home COVID-19 tests a month for every person on their plans, beginning Saturday, under a new policy the Biden administration detailed Monday. The administration is offering incentives for insurers and group health plans to partner with specific retailers so members can get tests with no upfront costs, but everyone with private insurance will be able to get reimbursed for tests purchased Jan. 15 or later.
After taking flak in December for a national shortage of test kits over the holidays, just as the Omicron variant started sweeping through the U.S., the Biden administration "is working to make COVID-19 home tests more accessible, both by increasing supply and bringing down costs," The Associated Press reports. People without private insurance or on Medicare will be able to request free kits directly from the federal government through a website the Biden administration is set to launch later this month.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The research is mixed on how effective the rapid at-home antigen tests are at detecting Omicron infections, The Wall Street Journal reports, and there are special concerns about false negatives early in an infection. If used correctly, though, they are an important tool for limiting the spread of the highly transmissible variant.
There are several approved at-home tests, and if you have a choice, the nonprofit group ECRI rates On/Go, CareStart, and Flowflex brand tests as "very good"; QuickVue, BinaxNOW, and InteliSwab as "good"; and BD Veritor as "OK (Marginally Acceptable)." You can read the pros and cons of each at-home test in their report.
The new Biden administration policy "will help millions of families afford COVID tests that allow them to be in school, visit family members, and live their lives," Sabrina Corlette, co-director of Georgetown University's Center on Health Insurance Reforms, tells the Journal. "It's not perfect, and there will be glitches, but the cost of these tests has been a huge barrier for many people, and this policy helps lower that."
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
